Skip to main content
Caplight Logo









GynQura Therapeutics

GynQura Therapeutics

Private
CopenhagenHealthcare & Life Scienceshttps://gynqura.com

Last Round

Grant

Aug 14, 2025

Total Funding Raised

$2.83M

Company Overview

GynQura Therapeutics operates in Healthcare & Life Sciences and is based in Copenhagen. Its latest recorded funding round was a Grant round in August 2025.

GynQura Therapeutics is a biotechnology company developing non-hormonal, disease-modifying therapies for endometriosis using a patient-derived organoid platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

GynQura Therapeutics Comparables

Compare GynQura Therapeutics with similar companies based on industry and business-model similarity.

GynQura Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cyclana Bio
87%
Rosebud Biosciences
70%
EndoGene.Bio
66%
Book a demo to see all comparables

For institutional investors. Book with your work email.

GynQura Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 14, 2025
AcceleratorJan 23, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

GynQura Therapeutics Investors

Notable investors and investment history

GynQura Therapeutics investors
InvestorRounds
EQT FoundationGrant
BioInnovation InstituteAccelerator

GynQura Therapeutics Filings

Explore SEC and related filing metadata, where available.

GynQura Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about GynQura Therapeutics's valuation, stock price, and market status.

Is GynQura Therapeutics a public or private company?

GynQura Therapeutics is a private company.

What is the current stock price of GynQura Therapeutics?

GynQura Therapeutics is a private company, so its shares have no public market price. Caplight tracks GynQura Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is GynQura Therapeutics worth (valuation)?

Valuation information for GynQura Therapeutics is not publicly available.

Can I buy GynQura Therapeutics stock?

GynQura Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was GynQura Therapeutics's last funding round?

GynQura Therapeutics's most recent funding round was Grant on August 14, 2025.

Who are the main investors in GynQura Therapeutics?

Key investors in GynQura Therapeutics include EQT Foundation, BioInnovation Institute.

Will GynQura Therapeutics IPO soon?

No public IPO plans have been announced for GynQura Therapeutics.

How can I track GynQura Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades in GynQura Therapeutics's shares on secondary markets.

Firmographic Details

HeadquartersCopenhagen
Year FoundedN/A
Last FundingAug 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?